CooperCompanies Announces New Board Appointments
March 24 2021 - 4:15PM
CooperCompanies (NYSE: COO) announced today that its Board of
Directors elected Robert S. Weiss as Chairman of the Board and
William A. Kozy as Vice Chairman and Lead Director. Both
appointments are effective March 23, 2021.
“Bob and Bill’s broad management experience and deep knowledge
of the medical device industry is incredibly valuable as we
continue to grow the business,” said Al White, Cooper’s President
and CEO. “I look forward to working closely with them in their new
roles to ensure Cooper continues to have a positive impact on all
our stakeholders.”
Mr. Weiss has served on the CooperCompanies Board since 1996. He
succeeds A. Thomas Bender as Chairman of the Board. After a long
and distinguished career with Cooper, which included serving as
President and CEO from 1995 to 2007 and Chairman from 2002 to March
2021, Mr. Bender announced his retirement from the Board in
December 2020.
Mr. Weiss held several leadership positions with Cooper during
his career. He served as President of CooperCompanies from March
2008 and as CEO from November 2007 until his retirement in May
2018. Prior to that, he served as Chief Operating Officer of
CooperCompanies from 2005 to 2007 and as Executive Vice President
from 1995 to 2007. Earlier, he served as Chief Financial Officer
from 1989 to 2005 and Treasurer from 1989 to 2002.
Mr. Kozy was first elected to the CooperCompanies Board in 2016.
He succeeds Allan E. Rubenstein, M.D., as Vice Chairman and Lead
Director. Dr. Rubenstein announced his retirement from the Board in
December 2020 after many positive years supporting the Company’s
growth initiatives.
Mr. Kozy served as the Chief Operating Officer of Becton
Dickinson from 2012 until his retirement in 2016 and as its
Executive Vice President from 2006 until 2016. He also served as a
member of the Corporate Leadership Team for Becton Dickinson and in
various executive roles since 1988, including Senior Vice President
of Company Operations, President of BD Diagnostics, President of
the BD Biosciences segment, and head of BD Medical.About
CooperCompaniesCooperCompanies ("Cooper") is a global
medical device company publicly traded on the NYSE (NYSE: COO).
Cooper operates through two business units, CooperVision and
CooperSurgical. CooperVision brings a refreshing perspective on
vision care with a commitment to developing a wide range of
high-quality products for contact lens wearers and providing
focused practitioner support. CooperSurgical is committed to
advancing the health of women, babies, and families with its
diversified portfolio of products and services focusing on medical
devices and fertility & genomics. Headquartered in San Ramon,
CA, Cooper has a workforce of more than 12,000 with products sold
in over 100 countries. For more information, please visit
www.coopercos.com.
CONTACT:Kim DuncanVice President, Investor
Relations and Risk Management925-460-3663ir@cooperco.com
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Apr 2023 to Apr 2024